We are live on ! Find out more
EHWM

Eads & Heald Wealth Management Portfolio holdings

AUM $201M
1-Year Est. Return 21.29%
This Fund
S&P 500
This Quarter Est. Return
+1.91%
1 Year Est. Return
+21.29%
3 Year Est. Return
+70.18%
5 Year Est. Return
+104.01%
10 Year Est. Return
+364.64%
AUM
$147M
AUM Growth
+$1.46M
Cap. Flow
+$183K
Cap. Flow %
0.12%
Top 10 Hldgs %
14.79%
Holding
136
New
6
Increased
51
Reduced
68
Closed
4

Top Sells

Rank Stock Value
1
AGN
Allergan plc
AGN
+$751K
2
GILD icon
Gilead Sciences
GILD
+$353K
3
BBWI icon
Bath & Body Works
BBWI
+$296K
4
TOL icon
Toll Brothers
TOL
+$245K
5
EFX icon
Equifax
EFX
+$217K

Sector Composition

Rank Sector Weight
1 Healthcare 16.06%
2 Industrials 15.91%
3 Technology 13.91%
4 Consumer Staples 12.85%
5 Consumer Discretionary 11.14%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
JPM icon
1
JPMorgan Chase
JPM
$925B
$2.39M 1.63%
27,704
-2,139
-7% -$163K
AMZN icon
2
Amazon
AMZN
$2.51T
$2.39M 1.63%
63,740
+4,040
+7% +$158K
ITW icon
3
Illinois Tool Works
ITW
$78.9B
$2.22M 1.52%
18,144
-653
-3% -$78.9K
SYK icon
4
Stryker
SYK
$121B
$2.22M 1.52%
18,546
-184
-1% -$21.2K
CVX icon
5
Chevron
CVX
$389B
$2.15M 1.46%
18,243
+74
+0.4% +$8.06K
COST icon
6
Costco
COST
$409B
$2.1M 1.43%
13,109
+113
+0.9% +$17.3K
FISV
7
Fiserv Inc
FISV
$26.7B
$2.09M 1.42%
39,294
-554
-1% -$28.5K
PEP icon
8
PepsiCo
PEP
$184B
$2.05M 1.4%
19,610
+153
+0.8% +$16K
DIS icon
9
Walt Disney
DIS
$162B
$2.05M 1.4%
19,675
+182
+0.9% +$17.7K
JNJ icon
10
Johnson & Johnson
JNJ
$623B
$2.02M 1.38%
17,528
+80
+0.5% +$9.24K
V icon
11
Visa
V
$667B
$2M 1.36%
25,608
-116
-0.5% -$9.33K
TMO icon
12
Thermo Fisher Scientific
TMO
$213B
$1.99M 1.36%
14,134
-89
-0.6% -$13.1K
RTX icon
13
RTX Corp
RTX
$281B
$1.97M 1.34%
28,589
-229
-0.8% -$15.2K
XOM icon
14
ExxonMobil
XOM
$654B
$1.97M 1.34%
21,825
-62
-0.3% -$5.42K
BALL icon
15
Ball Corp
BALL
$16.5B
$1.97M 1.34%
52,416
-230
-0.4% -$8.89K
AAPL icon
16
Apple
AAPL
$4.71T
$1.96M 1.34%
67,760
-184
-0.3% -$5.22K
CTSH icon
17
Cognizant
CTSH
$20.2B
$1.87M 1.28%
33,411
+155
+0.5% +$8.29K
ADP icon
18
Automatic Data Processing
ADP
$96.8B
$1.87M 1.27%
18,172
-530
-3% -$49.5K
CHD icon
19
Church & Dwight Co
CHD
$22.6B
$1.85M 1.26%
41,828
+250
+0.6% +$11.4K
CL icon
20
Colgate-Palmolive
CL
$71.6B
$1.85M 1.26%
28,220
+135
+0.5% +$9.26K
AFL icon
21
Aflac
AFL
$63.3B
$1.83M 1.25%
52,578
+710
+1% +$25K
MMM icon
22
3M
MMM
$87.4B
$1.83M 1.25%
12,247
-8
-0.1% -$1.15K
ECL icon
23
Ecolab
ECL
$74B
$1.82M 1.24%
15,551
+200
+1% +$23.4K
APH icon
24
Amphenol
APH
$193B
$1.82M 1.24%
108,364
-5,944
-5% -$99K
PG icon
25
Procter & Gamble
PG
$340B
$1.81M 1.23%
21,522
+117
+0.5% +$9.97K

Similar funds

Eads & Heald Wealth Management's Q4 2016 Portfolio in Review

As of Q4 2016, Eads & Heald Wealth Management held 136 positions worth $147M, up 1% from $145M the previous quarter. Its ten largest holdings account for 15% of the portfolio.

Eads & Heald Wealth Management's Q4 2016 filing shows 6 new, 51 increased, 68 reduced and 4 closed positions. Its largest new stake was Vulcan Materials: 2,250 shares worth $282K. The largest sale was Allergan plc, an estimated $751K.

By sector, the portfolio is most concentrated in Healthcare at 16% of assets, down from 18% a quarter earlier, followed by Industrials and Technology.

  • Eads & Heald Wealth Management's largest Q4 2016 buy was Vulcan Materials: 2,250 shares worth $282K.
  • Eads & Heald Wealth Management added most to Meta Platforms (Facebook) in Q4 2016, an estimated $773K increase.
  • Eads & Heald Wealth Management's biggest Q4 2016 reduction was Allergan plc, cutting an estimated $751K.
  • Eads & Heald Wealth Management fully exited Gilead Sciences in Q4 2016, selling an estimated $353K.
  • Eads & Heald Wealth Management's ten largest holdings make up 15% of its $147M portfolio in Q4 2016.
  • Eads & Heald Wealth Management opened 6 new positions and closed 4 in Q4 2016.
  • Eads & Heald Wealth Management's portfolio value rose 1% quarter-over-quarter to $147M.

Based on Eads & Heald Wealth Management's 13F filing for Q4 2016, filed 13 Feb 2017.